✨ Fisheries and Health Notices
34
NEW ZEALAND GAZETTE, No. 1
12 JANUARY 2006
JIM ANDERTON, Minister of Fisheries.
Dated at Wellington this 23rd day of December 2005.
Explanatory Note
This note is not part of the notice, but is intended to indicate its general effect.
The intent of this notice is to ensure implementation of effective devices to deter seabirds from interacting with trawl warp cables. This notice, which only applies to trawl vessels 28 metres and over, prohibits fishing in FMA3, FMA4, FMA5, FMA6, and FMA7 unless the vessel has a warp strike mitigation device deployed.
New Zealand Gazette, 15 September 2005, No. 158, page 3957
†New Zealand Gazette, 15 September 2005, No. 158, page 3959
go207
Health
Medicines Act 1981
Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Rapamune
Active Ingredient: Sirolimus 2mg
Dosage Form: Coated tablet
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturers: Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, Rouses Point, New York, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Product: Rilutek
Active Ingredient: Riluzole 50mg
Dosage Form: Tablet
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: Aventis Pharma (Nenagh) Limited, Nenagh, Co. Tipperary, Ireland
Note: This consent is subject to the following condition:
● Rilutek can only be prescribed by specialist physicians who care for patients with motor neurone disease, neurologists and palliative care physicians.
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 5th day of January 2006.
CYNTHIA MALING, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go176
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Lescol XL
Active Ingredient: Fluvastatin sodium 84.24mg equivalent to 80mg fluvastatin
Dosage Form: Modified release tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers: Novartis Farmaceutica SA, Barbera del Valles, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25µg/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Chiron S.r.l, Bellaria, Rosia, Sovicille, Italy
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 1
Gazette.govt.nz —
NZ Gazette 2006, No 1
✨ LLM interpretation of page content
🌾
Fisheries (Incidental Bycatch of Seabirds by Trawl Vessels 28m+) Notice 2006
(continued from previous page)
🌾 Primary Industries & Resources23 December 2005
Fisheries, Seabirds, Bycatch, Trawl Vessels, Mitigation Devices, Warp Deflector, Diagram
- JIM ANDERTON, Minister of Fisheries
🏥 Provisional Consent to the Distribution of New Medicines
🏥 Health & Social Welfare5 January 2006
Medicines, Provisional Consent, Rapamune, Rilutek, Distribution
- CYNTHIA MALING, Acting-Deputy Director-General, Public Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare5 January 2006
Medicines, Consent, Lescol XL, MeNZB, Distribution
- CYNTHIA MALING, Acting-Deputy Director-General, Public Health